Lawrence Einhorn

发表

A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group

Lynne Wagner, Dennis P. West, Ethan Basch, 2010, Supportive Care in Cancer.

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.

Miklos Pless, N. Hanna, C. Desch, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology.

Cynthia S. Johnson, Constantin Yiannoutsos, Thomas Anderson, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.